The soluble guanylyl cyclase activator BAY 60-2770 ameliorates overactive bladder in obese mice

Journal of Urology

Volumn 191, Issue 2, 2014, Pages 539-547

  Leiria, Luiz O ^a   Silva, Fabio H ^a   Davel, Ana Paula C ^a   Alexandre, Eduardo C ^a   Calixto, Marina C ^a   De Nucci, Gilberto ^a   Mónica, Fabíola Z ^a   Antunes, Edson ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

lower urinary tract symptoms; obesity; overactive; reactive oxygen species; soluble guanylyl cyclase; urinary bladder

Indexed keywords

BAY 60 2770; CALCIUM CHLORIDE; CARBACHOL; CYCLIC GMP; GUANYLATE CYCLASE; GUANYLATE CYCLASE ACTIVATOR; GUANYLATE CYCLASE ALPHA 1; GUANYLATE CYCLASE BETA1; POTASSIUM CHLORIDE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; BAY 60 2270; CHOLESTEROL; GLUCOSE; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CONTRACTION; CONTROLLED STUDY; CYSTOMETRY; DRUG EFFECT; MALE; MICTURITION; MOUSE; NONHUMAN; OBESITY; OVERACTIVE BLADDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT DURATION; ANIMAL CELL; CHOLESTEROL BLOOD LEVEL; DIET RESTRICTION; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; LIPID DIET; MICTURITION DISORDER; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING;

CGMP; CYCLIC GUANOSINE MONOPHOSPHATE; LDL; LOW DENSITY LIPOPROTEIN; LOWER URINARY TRACT SYMPTOMS; NITRIC OXIDE; NO; NONVOIDING CONTRACTION; NVC; OAB; OBESITY; OVERACTIVE; OVERACTIVE BLADDER; REACTIVE OXYGEN SPECIES; ROS; SGC; SOLUBLE GUANYLATE CYCLASE; SOLUBLE GUANYLYL CYCLASE; URINARY BLADDER;

ANIMALS; BENZOATES; BIPHENYL COMPOUNDS; BLOTTING, WESTERN; ENZYME ACTIVATORS; GUANYLATE CYCLASE; HYDROCARBONS, FLUORINATED; LOWER URINARY TRACT SYMPTOMS; MALE; MICE; MICE, INBRED C57BL; OBESITY; REACTIVE OXYGEN SPECIES; URINARY BLADDER, OVERACTIVE;

EID: 84891926327     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.09.020     Document Type: Article

References (30)

1. H.E. Richter, K. Kenton, and L. Huang et al. The impact of obesity on urinary incontinence symptoms, severity, urodynamic characteristics and quality of life J Urol 183 2010 622
2. Y.C. Tong, and J.T. Cheng Alterations of M2,3-muscarinic receptor protein and mRNA expression in the bladder of the fructose fed obese rat J Urol 178 2007 1537
3. W.C. Lee, Y.C. Chuang, and P.H. Chiang et al. Pathophysiological studies of overactive bladder and bladder motor dysfunction in a rat model of metabolic syndrome J Urol 186 2011 318
4. N.U. Rahman, S. Phonsombat, and D. Bochinski et al. An animal model to study lower urinary tract and erectile dysfunction: the hyperlipidaemic rat BJU Int 100 2007 658
5. L.O. Leiria, C. Sollon, and M.C. Calixto et al. Role of PKC and CaV1.2 in detrusor overactivity in a model of obesity associated with insulin resistance in mice PLoS One 7 2012 e48507
6. L.O. Leiria, C. Sollon, and F.R. Báu et al. Insulin relaxes human and mice bladder via PI3K/AKT/eNOS pathway activation in mucosal cells: UPR-dependent insulin resistance as a cause of obesity-associated overactive bladder J Physiol 591 2013 2259
7. Z. Wang, Z. Cheng, and V. Cristofaro et al. Inhibition of TNF-α improves the bladder dysfunction that is associated with type 2 diabetes Diabetes 61 2012 2134
8. K.E. Andersson, and A. Arner Urinary bladder contraction and relaxation: physiology and pathophysiology Physiol Rev 84 2004 935
9. F.Z. Mónica, A.A. Bricola, and F.R. Báu et al. Long-term nitric oxide deficiency causes muscarinic supersensitivity and reduces beta(3)-adrenoceptor-mediated relaxation, causing rat detrusor overactivity Br J Pharmacol 153 2008 1659
10. J.P. Stasch, E.M. Becker, and C. Alonso-Alija et al. NO-independent regulatory site on soluble guanylate cyclase Nature 410 2001 212
11. O.V. Evgenov, P. Pacher, and P.M. Schmidt et al. NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential Nat Rev Drug Discov 5 2006 755
12. L.S. Hoffmann, P.M. Schmidt, and Y. Keim et al. Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation Br J Pharmacol 157 2009 781
13. F.Z. Mónica, R. Reges, and D. Cohen et al. Long-term administration of BAY 41-2272 prevents bladder dysfunction in nitric oxide-deficient rats Neurourol Urodyn 30 2011 456
14. J.P. Stasch, P.M. Schmidt, and P.I. Nedvetsky et al. Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels J Clin Invest 116 2006 2552
15. J.N. Cornu, P. Abrams, and C.R. Chapple et al. A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management: a systematic review and meta-analysis Eur Urol 62 2012 877
16. A. Kanai, I. Zabbarova, and M. Oefelein et al. Mechanisms of action of botulinum neurotoxins, β3-adrenergic receptor agonists, and PDE5 inhibitors in modulating detrusor function in overactive bladders: ICI-RS 2011 Neurourol Urodyn 31 2012 300
17. G.F. Lasker, E.A. Pankey, and T.J. Frink et al. The sGC activator BAY 60-2770 has potent erectile activity in the rat Am J Physiol Heart Circ Physiol 304 2013 H1670
18. V.O. Melichar, D. Behr-Roussel, and U. Zabel et al. Reduced cGMP signaling associated with neointimal proliferation and vascular dysfunction in late-stage atherosclerosis Proc Natl Acad Sci U S A 101 2004 16671
19. S. Kagota, A. Tamashiro, and Y. Yamaguchi et al. Downregulation of vascular soluble guanylate cyclase induced by high salt intake in spontaneously hypertensive rats Br J Pharmacol 134 2001 737
20. J.P. Stasch, P. Pacher, and O.V. Evgenov Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease Circulation 123 2011 2263
21. N. Weissmann, S. Hackemack, and B.K. Dahal et al. The soluble guanylate cyclase activator HMR1766 reverses hypoxia-induced experimental pulmonary hypertension in mice Am J Physiol Lung Cell Mol Physiol 297 2009 L658
22. S. Meurer, S. Pioch, and T. Pabst et al. Nitric oxide-independent vasodilator rescues heme-oxidized soluble guanylate cyclase from proteasomal degradation Circ Res 105 2009 33
23. L.E. Olsson, M.A. Wheeler, and W.C. Sessa et al. Bladder instillation and intraperitoneal injection of Escherichia coli lipopolysaccharide up-regulate cytokines and iNOS in rat urinary bladder J Pharmacol Exp Ther 284 1998 1203
24. O. Yalçin, F. Karataş, and F.A. Erulaş et al. The levels of glutathione peroxidase, vitamin A, E, C and lipid peroxidation in patients with transitional cell carcinoma of the bladder BJU Int 93 2004 863
25. M. Saito, H. Suzuki, and M. Yamada et al. Preventive effect of long-chain fatty alcohol on ischemia-reperfusion injury in the rat bladder Eur J Pharmacol 454 2002 81
26. M. Perše, R. Injac, and A. Erman Oxidative status and lipofuscin accumulation in urothelial cells of bladder in aging mice PLoS One 8 2013 e59638
27. H.H. Schmidt, P. Schmidt, and J.P. Stasch NO and haem-independent soluble guanylyl cyclase activators Hand Exp Pharmacol 191 2009 309
28. Y.C. Huang, A.W. Shindel, and H. Ning et al. Adipose derived stem cells ameliorate hyperlipidemia associated detrusor overactivity in a rat model J Urol 183 2010 1232
29. Y. Zhu, M. Xia, and Y. Yang et al. Purified anthocyanin supplementation improves endothelial function via NO-cGMP activation in hypercholesterolemic individuals Clin Chem 57 2011 1524
30. K.E. Andersson, N. Martin, and V. Nitti Selective β3-adrenoceptor agonists in the treatment of the overactive bladder J Urol 190 2013 1173